Assessment of Alzheimer's disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Alzheimer's disease (AD) is a devastating illness, affecting over 5.5 million adults in the United States and costing over 170 billion dollars annually. In addition, there is growing recognition that mild cognitive impairment (MCI) constitutes a risk factor for AD and other neurodegenerative disorders. In this chapter, we describe the clinical manifestations of early AD and other neurogenerative brain disorders and describe the appropriate neuropsychological measures that tap the important cognitive domains that should be assessed in these conditions. A summary of useful clinical tips as well as future directions in the field are addressed.

Original languageEnglish (US)
Title of host publicationHandbook on the Neuropsychology of Aging and Dementia
PublisherSpringer New York
Pages271-280
Number of pages10
ISBN (Electronic)9781461431060
ISBN (Print)9781461431053
DOIs
StatePublished - Jan 1 2013

Keywords

  • Alzheimer's
  • Cognitive assessment
  • Early alzheimer's disease
  • MCI diagnosis

ASJC Scopus subject areas

  • Psychology(all)

Fingerprint Dive into the research topics of 'Assessment of Alzheimer's disease'. Together they form a unique fingerprint.

Cite this